Cargando…
P2Y(2)R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer
In the tumor microenvironment, extracellular nucleotides are released and accumulate, and can activate the P2Y(2) receptor (P2Y(2)R), which regulates various responses in tumor cells, resulting in tumor progression and metastasis. Moreover, the inflammasome has recently been reported to be associate...
Autores principales: | Jin, Hana, Ko, Young Shin, Kim, Hye Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192788/ https://www.ncbi.nlm.nih.gov/pubmed/30226596 http://dx.doi.org/10.3892/ijo.2018.4552 |
Ejemplares similares
-
NLRC4, ASC and Caspase-1 Are Inflammasome Components That Are Mediated by P2Y(2)R Activation in Breast Cancer Cells
por: Jin, Hana, et al.
Publicado: (2020) -
ESM-1 Overexpression is Involved in Increased Tumorigenesis of Radiotherapy-Resistant Breast Cancer Cells
por: Jin, Hana, et al.
Publicado: (2020) -
Increased Extracellular Adenosine in Radiotherapy-Resistant Breast Cancer Cells Enhances Tumor Progression through A2AR-Akt-β-Catenin Signaling
por: Jin, Hana, et al.
Publicado: (2021) -
Radiotherapy-Resistant Breast Cancer Cells Enhance Tumor Progression by Enhancing Premetastatic Niche Formation through the HIF-1α-LOX Axis
por: Ko, Young Shin, et al.
Publicado: (2020) -
Mebendazole Increases Anticancer Activity of Radiotherapy in Radiotherapy-Resistant Triple-Negative Breast Cancer Cells by Enhancing Natural Killer Cell-Mediated Cytotoxicity
por: Choi, Hoon Sik, et al.
Publicado: (2022)